A British healthcare design firm has come out with a new drug-delivery device to add to its innovative portfolio: an auto-injector for rheumatoid arthritis patients. On its head, this might not sound ...
Amgen announced that the Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for the expanded indication of Enbrel (etanercept) injection to include ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results